The Role of IL5 in Epithelial Cell Integrity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Role of IL5 in Epithelial Cell Integrity — Stella

Home/Chronic Rhinosinusitis With Nasal Polyps/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Rhinosinusitis With Nasal Polyps trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

Johns Hopkins Bayview Medical Center, Baltimore, Maryland

Johns Hopkins Hospital, Baltimore, Maryland

Key details

Phase

Very early testing

Sponsor

Johns Hopkins University

Collaborators

GlaxoSmithKline

Enrollment target

~8 participants

Started

September 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 100 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.